Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells

Journal of Proteome Research

Volumn 11, Issue 12, 2012, Pages 6019-6029

  Fung, Kim Y C ^a   Ooi, Cheng Cheng ^a,b   Lewanowitsch, Tanya ^a   Tan, Sandra ^c   Tan, Hwee Tong ^d   Lim, Teck Kwang ^c   Lin, Qingsong ^c   Williams, Desmond B ^b   Lockett, Trevor J ^a   Cosgrove, Leah J ^a   Chung, Maxey C M ^c,d   Head, Richard J ^a  

^a CSIRO   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

3 hydroxybutyrate; 4 benzoylbutyrate; apoptosis; butyrate; proteomics

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 BENZOYLBUTYRATE; ANTINEOPLASTIC AGENT; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; HISTONE DEACETYLASE; HISTONE H4; MYC PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ENERGY; CELL PROLIFERATION; COLORECTAL CARCINOMA; ENERGY METABOLISM; HISTONE ACETYLATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

3-HYDROXYBUTYRIC ACID; ACETYLATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTYRATES; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYTOPLASM; ENZYME ACTIVATION; HCT116 CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HT29 CELLS; HUMANS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84870871423     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3007107     Document Type: Article

References (37)

1. Topping, D. L.; Clifton, P. M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides Physiol. Rev. 2001, 81 (3) 1031-64
2. Bonnotte, B.; Favre, N.; Reveneau, S.; Micheau, O.; Droin, N.; Garrido, C.; Fontana, A.; Chauffert, B.; Solary, E.; Martin, F. Cancer cell sensitization to fas-mediated apoptosis by sodium butyrate Cell Death Differ. 1998, 5 (6) 480-7
3. Fung, K. Y.; Brierley, G. V.; Henderson, S.; Hoffmann, P.; McColl, S. R.; Lockett, T.; Head, R.; Cosgrove, L. Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response J. Proteome Res. 2011, 10 (4) 1860-9
4. Fung, K. Y.; Lewanowitsch, T.; Henderson, S. T.; Priebe, I.; Hoffmann, P.; McColl, S. R.; Lockett, T.; Head, R.; Cosgrove, L. J. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells J. Proteome Res. 2009, 8 (3) 1220-7
5. Hinnebusch, B. F.; Meng, S.; Wu, J. T.; Archer, S. Y.; Hodin, R. A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation J. Nutr. 2002, 132 (5) 1012-7
6. Milovic, V.; Teller, I. C.; Turchanowa, L.; Caspary, W. F.; Stein, J. Effect of structural analogues of propionate and butyrate on colon cancer cell growth Int. J. Colorectal Dis. 2000, 15 (5-6) 264-70
7. Tan, S.; Seow, T. K.; Liang, R. C.; Koh, S.; Lee, C. P.; Chung, M. C.; Hooi, S. C. Proteome analysis of butyrate-treated human colon cancer cells (HT-29) Int. J. Cancer 2002, 98 (4) 523-31
8. Wu, J. T.; Archer, S. Y.; Hinnebusch, B.; Meng, S.; Hodin, R. A. Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis Am. J. Physiol.: Gastrointest. Liver Physiol. 2001, 280 (3) G482-90
9. Candido, E. P.; Reeves, R.; Davie, J. R. Sodium butyrate inhibits histone deacetylation in cultured cells Cell 1978, 14 (1) 105-13
10. Mann, B. S.; Johnson, J. R.; Cohen, M. H.; Justice, R.; Pazdur, R. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma Oncologist 2007, 12 (10) 1247-52
11. Kang, S. N.; Lee, E.; Lee, M. K.; Lim, S. J. Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma Drug Delivery 2011, 18 (2) 143-9
12. Li, Y.; Le Maux, S.; Xiao, H.; McClements, D. J. Emulsion-based delivery systems for tributyrin, a potential colon cancer preventative agent J. Agric. Food Chem. 2009, 57 (19) 9243-9
13. Marino, A. M.; Sofiadis, A.; Baryawno, N.; Johnsen, J. I.; Larsson, C.; Vukojevic, V.; Ekstrom, T. J. Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models Biochem. Biophys. Res. Commun. 2011, 411 (1) 208-12
14. Rada-Iglesias, A.; Enroth, S.; Ameur, A.; Koch, C. M.; Clelland, G. K.; Respuela-Alonso, P.; Wilcox, S.; Dovey, O. M.; Ellis, P. D.; Langford, C. F.; Dunham, I.; Komorowski, J.; Wadelius, C. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes Genome Res. 2007, 17 (6) 708-19
15. Tang, Y.; Chen, Y.; Jiang, H.; Robbins, G. T.; Nie, D. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer Int. J. Cancer 2011, 128 (4) 847-56
16. Thangaraju, M.; Cresci, G. A.; Liu, K.; Ananth, S.; Gnanaprakasam, J. P.; Browning, D. D.; Mellinger, J. D.; Smith, S. B.; Digby, G. J.; Lambert, N. A.; Prasad, P. D.; Ganapathy, V. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon Cancer Res. 2009, 69 (7) 2826-32
17. Yonezawa, T.; Kobayashi, Y.; Obara, Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line Cell. Signalling 2007, 19 (1) 185-93
18. Tan, H. T.; Tan, S.; Lin, Q.; Lim, T. K.; Hew, C. L.; Chung, M. C. Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells Mol. Cell. Proteomics 2008, 7 (6) 1174-85
19. Ooi, C. C.; Good, N. M.; Williams, D. B.; Lewanowitsch, T.; Cosgrove, L. J.; Lockett, T. J.; Head, R. J. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells Clin. Exp. Pharmacol. Physiol. 2010, 37 (9) 905-11
20. Ooi, C. C.; Good, N. M.; Williams, D. B.; Lewanowitsch, T.; Cosgrove, L. J.; Lockett, T. J.; Head, R. J. Efficacy of butyrate analogues in HT-29 cancer cells Clin. Exp. Pharmacol. Physiol. 2010, 37 (4) 482-9
21. Kiefer, J.; Beyer-Sehlmeyer, G.; Pool-Zobel, B. L. Mixtures of SCFA, composed according to physiologically available concentrations in the gut lumen, modulate histone acetylation in human HT29 colon cancer cells Br. J. Nutr. 2006, 96 (5) 803-10
22. Dundas, S. R.; Lawrie, L. C.; Rooney, P. H.; Murray, G. I. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival J. Pathol. 2005, 205 (1) 74-81
23. Yoon, S. Y.; Lee, Y.; Kim, J. H.; Chung, A. S.; Joo, J. H.; Kim, C. N.; Kim, N. S.; Choe, I. S.; Kim, J. W. Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein Biochem. Biophys. Res. Commun. 2005, 326 (1) 7-17
24. Zhang, D.; Richardson, D. R. Endoplasmic reticulum protein 29 (ERp29): An emerging role in cancer Int. J. Biochem. Cell Biol. 2011, 43 (1) 33-6
25. Grzmil, M.; Rzymski, T.; Milani, M.; Harris, A. L.; Capper, R. G.; Saunders, N. J.; Salhan, A.; Ragoussis, J.; Norbury, C. J. An oncogenic role of eIF3e/INT6 in human breast cancer Oncogene 2010, 29 (28) 4080-9
26. Mayeur, G. L.; Hershey, J. W. Malignant transformation by the eukaryotic translation initiation factor 3 subunit p48 (eIF3e) FEBS Lett. 2002, 514 (1) 49-54
27. Li, G.; Mongillo, M.; Chin, K. T.; Harding, H.; Ron, D.; Marks, A. R.; Tabas, I. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis J. Cell Biol. 2009, 186 (6) 783-92
28. Friedman, M. J.; Li, S.; Li, X. J. Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection J. Biol. Chem. 2009, 284 (41) 27944-51
29. Wang, J. J.; Liu, Y.; Zheng, Y.; Lin, F.; Cai, G. F.; Yao, X. Q. Comparative proteomics analysis of colorectal cancer Asian Pac. J. Cancer Prev. 2012, 13 (4) 1663-6
30. Jou, Y. C.; Tung, C. L.; Tsai, Y. S.; Shen, C. H.; Syue-Yi, C.; Shiau, A. L.; Tsai, H. T.; Wu, C. L.; Tzai, T. S. Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma Urology 2009, 74 (4) 951-7
31. Suzuki, S.; Takahashi, S.; Takeshita, K.; Hikosaka, A.; Wakita, T.; Nishiyama, N.; Fujita, T.; Okamura, T.; Shirai, T. Expression of prothymosin alpha is correlated with development and progression in human prostate cancers Prostate 2006, 66 (5) 463-9
32. Tsai, Y. S.; Jou, Y. C.; Lee, G. F.; Chen, Y. C.; Shiau, A. L.; Tsai, H. T.; Wu, C. L.; Tzai, T. S. Aberrant prothymosin-alpha expression in human bladder cancer Urology 2009, 73 (1) 188-92
33. Jiang, X.; Kim, H. E.; Shu, H.; Zhao, Y.; Zhang, H.; Kofron, J.; Donnelly, J.; Burns, D.; Ng, S. C.; Rosenberg, S.; Wang, X. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway Science 2003, 299 (5604) 223-6
34. Karapetian, R. N.; Evstafieva, A. G.; Abaeva, I. S.; Chichkova, N. V.; Filonov, G. S.; Rubtsov, Y. P.; Sukhacheva, E. A.; Melnikov, S. V.; Schneider, U.; Wanker, E. E.; Vartapetian, A. B. Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes Mol. Cell. Biol. 2005, 25 (3) 1089-99
35. Gale, N. W.; Kaplan, S.; Lowenstein, E. J.; Schlessinger, J.; Bar-Sagi, D. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras Nature 1993, 363 (6424) 88-92
36. Kondo, A.; Hirayama, N.; Sugito, Y.; Shono, M.; Tanaka, T.; Kitamura, N. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation J. Biol. Chem. 2008, 283 (3) 1428-36
37. Brummer, T.; Larance, M.; Herrera Abreu, M. T.; Lyons, R. J.; Timpson, P.; Emmerich, C. H.; Fleuren, E. D.; Lehrbach, G. M.; Schramek, D.; Guilhaus, M.; James, D. E.; Daly, R. J. Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein EMBO J. 2008, 27 (17) 2305-16